发明名称 |
Pharmaceutical compositions comprising NEP-inhibitors, inhibitors of the endogenous endothelin producing system and AT1 receptor antagonists |
摘要 |
A combination therapy for cardiovascular diseases, in particular essential hypertension, pulmonary hypertension and/or congestive heart failure, involving administering a synergistic combination of at least one inhibitor of neutral endopeptidase, at least one inhibitor of the endogenous endothelin producing system, and at least one AT<SUB>1 </SUB>receptor antagonist.
|
申请公布号 |
US2005288272(A1) |
申请公布日期 |
2005.12.29 |
申请号 |
US20050155782 |
申请日期 |
2005.06.20 |
申请人 |
SOLVAY PHARMACEUTICALS GMBH |
发明人 |
ZIEGLER DIETER;WITTE KLAUS;STRAUB MATTHIAS;FISCHER YVAN;THORMAEHLEN DIRK;HOELTJE DAGMAR |
分类号 |
A61K31/55;(IPC1-7):A61K31/55 |
主分类号 |
A61K31/55 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|